Last updated: August 16, 2022
Sponsor: University Hospital, Lille
Overall Status: Active - Recruiting
Phase
2/3
Condition
Sepsis And Septicemia
Low Blood Pressure (Hypotension)
Treatment
N/AClinical Study ID
NCT03528213
2015_56
2017-002393-39
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Presence of septic shock
- requiring vascular filling within 12 hours after introduction of Noradrenaline. Septicshock is defined as sepsis with persistent hypotension requiring the administration ofvasopressors to maintain RTE > 65mmHg.
- social insurance
Exclusion
Exclusion Criteria:
- pregnancy
- cardiac arrest
- more than 50ml/kg of fluid loading
- chronic renal failure with chronic hemodialysis or the investigators estimate a needfor renal replacement therapy in the following 24hrs
- child C or acute liver failure with PT<40% (unless AVK)
- plasmatic sodium <120 or >145mmol/l
- metabolic alkalosis with pH>7.45
Study Design
Total Participants: 90
Study Start date:
October 04, 2019
Estimated Completion Date:
November 30, 2023
Study Description
Connect with a study center
CH ARRAS
Arras,
FranceActive - Recruiting
CH DOUAI
Douai,
FranceActive - Recruiting
Ch Dunkerque
Dunkerque,
FranceActive - Recruiting
CH LENS
Lens,
FranceActive - Recruiting
Hôpital Roger Salengro, CHU
Lille,
FranceActive - Recruiting
Hopital Victor Provo - Roubaix
Roubaix,
FranceActive - Recruiting
Chu Rouen
Rouen,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.